Going skin deep [0.03%]
浅尝辄止
Klaus Eisendle,Lukas Kofler
Klaus Eisendle
K R van Straalen,L Thorlacius
K R van Straalen
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors [0.03%]
免疫检查点抑制剂治疗后的皮肤免疫相关不良事件的季节性和地域性差异
Ahmad Rajeh,Katie Roster,Kerry L Reynolds et al.
Ahmad Rajeh et al.
Fibrosis quantification in hidradenitis suppurativa tunnels: Histological correlation with shear wave elastography [0.03%]
HS窦道纤维化定量：剪切波弹性成像与组织病理学的相关性研究
Laura Mateu-Arrom,Anna Mozos,Lluis Puig et al.
Laura Mateu-Arrom et al.
Can Napoleon's skin disease and treatment be identified from paleoproteomic analyses of his last bathtub (1821)? [0.03%]
拿破仑的皮肤病及治疗能否通过古蛋白质组学分析其遗物浴缸（1821年）加以鉴别？
Philippe Charlier,Jean Armengaud,Joel Poupon et al.
Philippe Charlier et al.
Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One-year outcomes from the international noninterventional CIMREAL study [0.03%]
妊娠或哺乳期及育龄女性银屑病患者接受 Certolizumab pegol 治疗的临床结果：国际非干预性研究 CIMREAL 一年随访结果
Hillary Tom,Lovegrove Fiona,Boye Thierry et al.
Hillary Tom et al.
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment [0.03%]
欧洲S2K指南二期：化脓性汗腺炎/逆向型痤疮的治疗指导原则
C C Zouboulis,F G Bechara,F Benhadou et al.
C C Zouboulis et al.
Introduction: This second part of the S2k guidelines is an update of the 2015 S1 European guidelines. Objective: These guidelines aim t...
Discovering basal cell carcinoma cellular origin via reflectance confocal microscopy [0.03%]
共焦显微镜发现基底细胞癌的起源细胞类型
Luca Ambrosio,Vincenzo Roberti,Pablo Uribe et al.
Luca Ambrosio et al.